Abstract 5507: Mechanisms of resistance to RAS-GTP inhibition in pancreatic cancer
Joshua H. Choe(Columbia University), Andrew J. Aguirre(Broad Institute), Dennis Gong(Broad Institute), Lo Lai(Georgia State University), Eejung Kim(Broad Institute), Julien Dilly(Massachusetts Institute of Technology), David Wildes(Revolution Medicines (United States)), Kyle J. Seamon(Revolution Medicines (United States)), Brendan Parent(Unknown), Brian M. Wolpin(Brigham and Women's Hospital), William L. Hwang(Massachusetts General Hospital), Lewis C. Cantley(Cornell University), Channing J. Der(University of North Carolina at Chapel Hill), Jennifer A. Chan(University of Calgary), Fan Yi Kong(Dana-Farber Cancer Institute), Joseph D. Mancias(Brigham and Women's Hospital), Nicole Sindoni(Dana-Farber Cancer Institute), Junning Wang(Dana-Farber Cancer Institute), Jaclyn Varga-Wiles(Dana-Farber Cancer Institute), Clint A. Stalnecker(University of North Carolina at Chapel Hill)
Cited by 2
Related Papers
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
|Science|2007|4.5k
Gene regulation and DNA damage in the ageing human brain
|Nature|2004|1.9k
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k